DNA/RNA Electrochemical Biosensing Devices a Future Replacement of PCR Methods for a Fast Epidemic Containment.
Manikandan SanthanamItay AlgovLital AlfontaPublished in: Sensors (Basel, Switzerland) (2020)
Pandemics require a fast and immediate response to contain potential infectious carriers. In the recent 2020 Covid-19 worldwide pandemic, authorities all around the world have failed to identify potential carriers and contain it on time. Hence, a rapid and very sensitive testing method is required. Current diagnostic tools, reverse transcription PCR (RT-PCR) and real-time PCR (qPCR), have its pitfalls for quick pandemic containment such as the requirement for specialized professionals and instrumentation. Versatile electrochemical DNA/RNA sensors are a promising technological alternative for PCR based diagnosis. In an electrochemical DNA sensor, a nucleic acid hybridization event is converted into a quantifiable electrochemical signal. A critical challenge of electrochemical DNA sensors is sensitive detection of a low copy number of DNA/RNA in samples such as is the case for early onset of a disease. Signal amplification approaches are an important tool to overcome this sensitivity issue. In this review, the authors discuss the most recent signal amplification strategies employed in the electrochemical DNA/RNA diagnosis of pathogens.
Keyphrases
- nucleic acid
- gold nanoparticles
- real time pcr
- early onset
- label free
- coronavirus disease
- sars cov
- circulating tumor
- copy number
- ionic liquid
- sensitive detection
- single molecule
- cell free
- late onset
- mitochondrial dna
- genome wide
- dna methylation
- mass spectrometry
- quantum dots
- low cost
- risk assessment
- gram negative
- gene expression
- high resolution
- human health